AI assistant
Sending…
Applied Therapeutics, Inc. — Director's Dealing 2026
Jan 2, 2026
34263_dirs_2026-01-02_92477672-2ba9-45c4-9ff2-faeef5082948.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2026-01-01
Reporting Person: Funtleyder Leslie D. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-01-01 | Common Stock | A | 150000 | — | Acquired | 1340459 | Direct |
Footnotes
F1: Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory RSU represents a contingent right to receive one share of the Issuer's
common stock. The compensatory RSUs shall vest in equal monthly installments over the twenty-four month period immediately following January 1, 2026, subject to the Reporting Person continuing to provide services through each such
date.
More from Applied Therapeutics, Inc.
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Delisting Announcement
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3